These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18385603)

  • 1. Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study.
    Garey KW; Jiang ZD; Bellard A; Dupont HL
    J Clin Gastroenterol; 2009 Jan; 43(1):91-3. PubMed ID: 18385603
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.
    Garey KW; Ghantoji SS; Shah DN; Habib M; Arora V; Jiang ZD; DuPont HL
    J Antimicrob Chemother; 2011 Dec; 66(12):2850-5. PubMed ID: 21948965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of recurrent Clostridium difficile diarrhoea using sequential therapy with vancomycin followed by rifaximin].
    Zelada Rodríguez MA; Rodríguez D; Martí X; Espejo E
    Rev Esp Geriatr Gerontol; 2012; 47(1):42-4. PubMed ID: 22105006
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifaximin in the treatment of recurrent Clostridium difficile infection.
    Mattila E; Arkkila P; Mattila PS; Tarkka E; Tissari P; Anttila VJ
    Aliment Pharmacol Ther; 2013 Jan; 37(1):122-8. PubMed ID: 23095030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.
    Johnson S; Schriever C; Patel U; Patel T; Hecht DW; Gerding DN
    Anaerobe; 2009 Dec; 15(6):290-1. PubMed ID: 19698797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series.
    Neff G; Zacharias V; Kaiser TE; Gaddis A; Kemmer N
    Liver Transpl; 2010 Aug; 16(8):960-3. PubMed ID: 20677286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline as last resort in severe refractory Clostridium difficile infection: a case report.
    Knafl D; Winhofer Y; Lötsch F; Weisshaar S; Steininger C; Burgmann H; Thalhammer F
    J Hosp Infect; 2016 Mar; 92(3):296-8. PubMed ID: 26810610
    [No Abstract]   [Full Text] [Related]  

  • 8. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.
    Johnson S; Schriever C; Galang M; Kelly CP; Gerding DN
    Clin Infect Dis; 2007 Mar; 44(6):846-8. PubMed ID: 17304459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea.
    Garey KW; Salazar M; Shah D; Rodrigue R; DuPont HL
    Ann Pharmacother; 2008 Jun; 42(6):827-35. PubMed ID: 18430792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity reactions associated with fidaxomicin use.
    Iarikov DE; Alexander J; Nambiar S
    Clin Infect Dis; 2014 Feb; 58(4):537-9. PubMed ID: 24178248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of first recurrence of Clostridium difficile infections in children.
    Tschudin-Sutter S; Tamma PD; Milstone AM; Perl TM
    Pediatr Infect Dis J; 2014 Apr; 33(4):414-6. PubMed ID: 24168983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Bishara J; Wattad M; Paul M
    Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
    [No Abstract]   [Full Text] [Related]  

  • 13. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea.
    Berman AL
    J Clin Gastroenterol; 2007; 41(10):932-3. PubMed ID: 18090164
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
    Huggan PJ; Murdoch DR
    Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.
    Kokkotou E; Moss AC; Michos A; Espinoza D; Cloud JW; Mustafa N; O'Brien M; Pothoulakis C; Kelly CP
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1121-6. PubMed ID: 18195066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
    El-Herte RI; Baban TA; Kanj SS
    Scand J Infect Dis; 2012 Mar; 44(3):228-30. PubMed ID: 22077098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile-associated disease treatment response depends on definition of cure.
    Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
    Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
    Ohl ME; Stevermer JJ; Meadows S; Tribuna J; Chek K
    J Fam Pract; 2005 Feb; 54(2):176-8. PubMed ID: 15689297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.